Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.472, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olanzapine document leak rocks the boat for Eli Lilly
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
Access to resources
Recommend
An overview of CNS drug discovery at Eli Lilly and Company
By Paul S.M.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Generic drug programmes could save billions
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 625, 2011-01 ,pp. :
Eli Lilly - DNA patenting through the ages
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. :
Atomoxetine [Strattera; Eli Lilly] has been launched in the UK
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :